LaserAway is exploring a sale that could value the medical spa chain at more than $2B. The Los Angeles-based provider generates approximately $150M in annual EBITDA across 219 locations. This potential transaction highlights the growing private equity appetite for medical aesthetics businesses that offer high recurring revenue through repeat treatments.

Private Equity Interest Drives Sector Valuations